Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

3.9K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.9K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.

European journal of cancer (Oxford, England : 1990)·2018
Same author

Death in the New Town: Edinburgh's hidden story of stonemasons' silicosis.

The journal of the Royal College of Physicians of Edinburgh·2018
Same author

James Craufurd Gregory, 19th century Scottish physicians, and the link between occupation as a coal miner and lung disease.

The journal of the Royal College of Physicians of Edinburgh·2018
Same author

Evaluation of hibergene loop-mediated isothermal amplification assay for detection of group B streptococcus in recto-vaginal swabs: a prospective diagnostic accuracy study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same journal

A Monte Carlo simulation for evaluating hypothetical mesothelioma risk in a person exposed to talcum powder.

Inhalation toxicology·2026
Same journal

Association of exposure to environmental heavy metals with markers of sepsis susceptibility: a population-based study from NHANES.

Inhalation toxicology·2026
Same journal

Regional and size-dependent effects of ambient agricultural particulate matter on Ah-receptor activity and inflammatory responses in human U937 macrophages.

Inhalation toxicology·2026
Same journal

Development of alveoli-distributed lung geometry for ferrets to predict particle deposition in the respiratory tract.

Inhalation toxicology·2026
Same journal

Concerns about methodology and inference in Davigo and colleagues' review of heated tobacco products.

Inhalation toxicology·2026
Same journal

Acute ozone exposure results in airway epithelial and immune cell disturbances in mice.

Inhalation toxicology·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

928

Systemic Effect of Particulate Air Pollution.

W MacNee1, X Y Li1, P Gilmour1

  • 1a Respiratory Medicine Unit, Medical School , University of Edinburgh , Edinburgh , Scotland.

Inhalation Toxicology
|September 15, 2015
PubMed
Summary
This summary is machine-generated.

Particulate air pollution (PM10) and its ultrafine components cause lung inflammation and systemic oxidative stress. Ultrafine particles increase factor VII, a risk factor for cardiovascular events, explaining pollution

More Related Videos

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.5K
Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System
08:48

Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System

Published on: December 21, 2016

9.3K

Related Experiment Videos

Last Updated: Apr 3, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

928
Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.5K
Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System
08:48

Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System

Published on: December 21, 2016

9.3K

Area of Science:

  • Environmental Health Sciences
  • Toxicology
  • Cardiovascular Research

Background:

  • Epidemiological studies link particulate air pollution (PM10) to cardiovascular disease (CVD) mortality and morbidity.
  • The precise mechanisms by which PM10 induces these adverse cardiovascular effects remain largely unknown.
  • A hypothesis suggests ultrafine PM10 components trigger lung inflammation via oxidative stress, activating inflammatory pathways.

Purpose of the Study:

  • To investigate the mechanisms by which PM10 and its ultrafine components induce local lung inflammation and systemic effects.
  • To test the hypothesis that PM10-induced lung inflammation leads to systemic oxidative stress and altered coagulation.
  • To elucidate the role of ultrafine particles in the cardiovascular risks associated with air pollution.

Main Methods:

  • In vivo studies using rats and in vitro studies with cultured airspace epithelial cells.
  • Exposure to environmental PM10, fine carbon black (CB), and ultrafine carbon black (UfCB) particles.
  • Assessment of lung inflammation, epithelial permeability, oxidative stress (plasma antioxidant capacity), NF-kB activation, and coagulation factors (Factor VII, fibrinogen).

Main Results:

  • Ultrafine carbon black (UfCB) and PM10, but not fine CB, induced local lung inflammation, increased epithelial permeability, and oxidative stress.
  • PM10 exposure activated NF-kB in airspace epithelial cells.
  • Inhalation of UfCB and PM10 instillation significantly decreased plasma antioxidant capacity in rats, indicating systemic oxidative stress.
  • UfCB inhalation led to increased plasma Factor VII levels, a coagulation factor associated with cardiovascular events, while CB did not.

Conclusions:

  • Ultrafine components of PM10 are key drivers of lung inflammation and oxidative stress.
  • PM10 exposure induces systemic oxidative stress and elevates Factor VII levels, contributing to cardiovascular risk.
  • These findings provide mechanistic insights into the link between particulate air pollution and cardiovascular morbidity/mortality.